サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1529723

植え込み型心拍リズム管理デバイスの市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2024年～2030年

Implantable Cardiac Rhythm Management Device Market Size, Share & Trends Analysis Report By Product (Pacemaker, ICDs, CRT), By End-use (Hospitals, Specialty Cardiac Centers), By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
植え込み型心拍リズム管理デバイスの市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2024年～2030年
出版日: 2024年07月10日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

植え込み型心拍リズム管理デバイス市場の成長と動向：

Grand View Research社の最新レポートによると、植え込み型心拍リズム管理デバイスの世界市場規模は2030年までに155億3,000万米ドルに達し、2024年から2030年までのCAGRは6.4％で成長すると予測されています。

CVD疾患に罹患しやすい世界の老年人口の増加と、これらの疾患の正確で効果的な診断に対する需要が、植え込み型心臓リズム管理（CRM）デバイスの成長の要因となっています。

心臓疾患は世界中で主要な死亡原因の1つであり、人口の大部分が一生のうちに何らかの心臓疾患に罹患しています。高齢者ほどリスクが高い一方で、CVDの有病率は若い世代でも増加しています。多忙なスケジュールと多忙なライフスタイルは、個人における高血圧の主な要因です。ペースメーカー、ICD、心臓再同期療法（CRT）など、心臓の性能を向上させるためにさまざまな植え込み型デバイスが使用されています。ペースメーカーは伝導障害や洞機能障害のために最も多く植え込まれている機器です。CRTとICDは比較的新しく、旧来のものよりも優れた技術が組み込まれています。

COVID-19パンデミックは市場、特にICDs市場に悪影響を及ぼし、2020年の需要と売上は低迷しました。病院が選択的手術を再開したため、売上は改善しました。しかし、いくつかの主要市場ではCOVID-19の進行が続いており、この年も不透明な状況が続いた。例えば、アボット社は、2020年第2四半期と第3四半期に病院ベースの事業が改善したと報告しました。しかし、多くの国々でCOVID-19の症例と入院が急増したため、2020年第4四半期には改善傾向が横ばいになるか、マイナスの影響を受けた。一方、日本光電工業は、パンデミックにより販売活動が抑制されたにもかかわらず、2020年の除細動器の売上高は力強い伸びを示しました。

心疾患は世界的に主要な死亡原因の一つであり、人口の多くが生涯に何らかの心疾患に罹患しています。高齢者ほどリスクが高いが、CVDの有病率は若い世代でも増加しています。ペースメーカー、ICD、心臓再同期療法（CRT）装置など、心臓の性能を向上させるためにさまざまな植え込み型装置が使用されています。植込み型ペースメーカーは主に伝導障害や洞機能障害に使用されています。

植え込み型心拍リズム管理デバイス市場レポートハイライト

  • 病院の最終用途セグメントは、2023年に68.9%を超える最大の収益シェアを獲得しました。この成長の背景には、製品のより深い浸透、大量の外科手術、患者数の増加があります。
  • ICD製品セグメントは2023年に最大の収益シェアを占めました。心臓再同期療法機器セグメントは予測期間中に最も速い成長率を記録すると予想されています。
  • 推定8,570万人の米国人（すなわち人口のほぼ34％）が、ストレスの多いライフスタイルのために高血圧や高血圧に苦しんでいます。2017年にほぼ2,340万人の米国人成人が糖尿病と診断され、さらに推定760万人の米国人成人が未診断の糖尿病患者です。世界的には、糖尿病の有病率は2030年には7.7%に増加すると予想されています。
  • CRT製品分野は、先進国における支援的な立法政策の実施、認知度の向上、製品使用のためのトレーニングプログラムの増加により、予測期間中に最も速い成長率を記録すると予測されます。
  • 北米は2023年の収益シェア47.6%以上で市場を独占しています。これは、心血管疾患の罹患率の増加、支持的な政府政策、有利な償還制度、認知度の上昇、トレーニングプログラム数の増加に起因しています。
  • アジア太平洋地域は、CVDの有病率の高さと急速な高齢化により、予測期間中に最も速いCAGRを示すと予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界の植え込み型心拍リズム管理デバイス市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • 植え込み型心拍リズム管理デバイス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 植え込み型心拍リズム管理デバイス市場：製品別推定・動向分析

  • 植え込み型心拍リズム管理デバイス市場：製品別ダッシュボード
  • 植え込み型心拍リズム管理デバイス市場：製品別変動分析
  • 植え込み型心拍リズム管理デバイス市場規模と予測および動向分析、製品別、2018～2030年
  • ペースメーカー
  • ICD
  • ブラウン管

第5章 植え込み型心拍リズム管理デバイス市場：最終用途別推定・動向分析

  • 植え込み型心拍リズム管理デバイス市場：最終用途別ダッシュボード
  • 植え込み型心拍リズム管理デバイス市場：最終用途別変動分析
  • 植え込み型心拍リズム管理デバイス市場規模と予測および動向分析、最終用途別、2018～2030年
  • 病院
  • 専門心臓センター
  • その他

第6章 植え込み型心拍リズム管理デバイス市場：国、製品、最終用途、最終用途別の地域推定・動向分析

  • 世界の植え込み型心拍リズム管理デバイス市場：地域別ダッシュボード
  • 市場規模と予測動向分析、2018年から2030年
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第7章 競合情勢

  • 主要メーカーによる最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要販売代理店およびチャネル パートナーのリスト
    • 主要顧客
    • 主要企業の市場シェア分析、2023 年
    • Medtronic
    • Abbott
    • Boston Scientific Corporation
    • Koninklijke Philips NV
    • Zoll Medical Corporation
    • Biotronik
    • Stryker
    • Schiller AG
    • Nihon Kohden Corporation
    • Microport Scientific Corporation
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Global implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global implantable CRM devices market, by end-use, 2018 - 2030
  • Table 5 Global implantable CRM devices market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America implantable CRM devices market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 U.S. implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Canada implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Mexico implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Mexico implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe implantable CRM devices market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 U.K. implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 U.K. implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Germany implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 21 Germany implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 France implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Italy implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 25 Italy implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Spain implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Spain implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Denmark implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 Denmark implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Sweden implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 31 Sweden implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Norway implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 Norway implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific implantable CRM devices market, by Country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Japan implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 38 Japan implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 China implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 40 China implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 India implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 42 India implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Australia implantable CRM devices market, by country, 2018 - 2030 (USD Million)
  • Table 44 Australia implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 45 Thailand implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 46 Thailand implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 South Korea implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 48 South Korea implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Latin America implantable CRM devices market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 51 Latin America implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Brazil implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 53 Brazil implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Argentina implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 55 Argentina implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 MEA implantable CRM devices market, by country, 2018 - 2030 (USD Million)
  • Table 57 MEA implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 58 MEA implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 South Africa implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 60 South Africa implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 UAE implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 64 UAE implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Kuwait implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 66 Kuwait implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Participant's overview
  • Table 68 Financial performance
  • Table 69 Key companies undergoing expansions
  • Table 70 Key companies undergoing acquisitions
  • Table 71 Key companies undergoing collaborations
  • Table 72 Key companies launching new products/services
  • Table 73 Key companies undergoing partnerships
  • Table 74 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Implantable CRM devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Implantable Cardiac Rhythm Management (CRM) devices market revenues, 2023 (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Implantable CRM devices market product outlook:
  • Fig. 14 Implantable CRM devices market: Product movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global pacemaker market, 2018 - 2030 (USD Million)
  • Fig. 17 Global conventional pacemakers market, 2018 - 2030 (USD Million)
  • Fig. 18 Global leadless pacemaker market, 2018 - 2030 (USD Million)
  • Fig. 19 Global ICDS market, 2018 - 2030 (USD Million)
  • Fig. 20 Global single chamber ICDs market, 2018 - 2030 (USD Million)
  • Fig. 21 Global dual chamber ICDs market, 2018 - 2030 (USD Million)
  • Fig. 22 Global CRT market, 2018 - 2030 (USD Million)
  • Fig. 23 Global CRT-defibrillator market, 2018 - 2030 (USD Million)
  • Fig. 24 Global CRT-pacemaker market, 2018 - 2030 (USD Million)
  • Fig. 25 Implantable CRM devices market end-use outlook:
  • Fig. 26 Implantable CRM devices market: end-use movement analysis
  • Fig. 27 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 28 Global specialty cardiac centers market, 2018 - 2030 (USD Million)
  • Fig. 29 Global others market, 2018 - 2030 (USD Million)
  • Fig. 30 Regional market place: Key takeaways
  • Fig. 31 North America implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Canada implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 37 U.K. implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 38 France implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 39 Italy implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 40 Spain implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 42 Japan implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 43 China implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 44 India implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 45 Australia implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 46 Latin America implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 47 Brazil implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 48 MEA implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 49 South Africa implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 51 Market Participant Categorization
  • Fig. 52 Strategy mapping
目次
Product Code: GVR-2-68038-882-4

Implantable Cardiac Rhythm Management Devices Market Growth & Trends:

The global implantable cardiac rhythm management devices market size is expected to reach USD 15.53 billion by 2030, registering to grow at a CAGR of 6.4% from 2024 to 2030 according to a new report by Grand View Research, The increasing global geriatric population prone to CVD diseases and the demand for accurate and effective diagnostics of these diseases are the factors contributing to the growth of implantable cardiac rhythm management (CRM) devices.

Cardiac disorders are one of the major causes of mortality around the world, with a large percentage of the population suffering from some form of cardiac disorder in their lifetime. While the older population is at a higher risk, the prevalence of CVDs is increasing in the younger generation as well. Hectic schedules and busy lifestyles are major factors for hypertension among individuals. Various implantable devices are being used for improved cardiac performance, including pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT) devices. Pacemakers are the most implanted devices for conduction disorders and sinus dysfunctions. CRT devices and ICDs are comparatively new and incorporate better technology than their older counterparts.

The COVID-19 pandemic adversely impacted the market, in particular the ICDs market, with dampened demand and sales during 2020. The sales improved as the hospitals resumed elective surgeries. However, the progression of COVID-19 in several key markets continued to create uncertainty during the year. Abbott, for instance, reported improvement in its hospital-based businesses during Q2 and Q3 2020. However, the improving trends flattened or were negatively impacted during Q4 2020 due to a sudden increase in COVID-19 cases and hospitalizations in many countries. Nihon Kohden, on the other hand, reported strong sales growth of defibrillators in 2020, despite inhibited sales activity due to the pandemic.

Cardiac disorders are one of the major causes of mortality around the world, with a large percentage of the population suffering from some form of cardiac disorder in their lifetime. While the older population is at a higher risk, the prevalence of CVDs is increasing in the younger generation as well. Various implantable devices are being used for improved cardiac performance, including pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT) devices. Implanted pacemakers are majorly used for conduction disorders and sinus dysfunctions.

Implantable Cardiac Rhythm Management Devices Market Report Highlights:

  • The hospital's end-use segment captured the largest revenue share of over 68.9% in 2023. The growth can be attributed to deeper product penetration, a large volume of surgical procedures, and rising patient footfall
  • The ICDs product segment held the largest revenue share in 2023. The cardiac resynchronization therapy devices segment is expected to register the fastest growth rate over the forecast period
  • An estimated 85.7 million Americans (i.e., almost 34% of the population) suffered from high blood pressure and hypertension due to stressful lifestyles. Almost 23.4 million American adults were diagnosed with diabetes in 2017, while an estimated additional 7.6 million American adults are undiagnosed diabetics. Globally, the prevalence of diabetes is expected to increase to 7.7% in 2030
  • The CRT product segment is anticipated to register the fastest growth rate over the forecast period due to the implementation of supportive legislative policies in developed countries and an increase in awareness and the number of training programs for use of the products
  • North America dominated the market with a revenue share of over 47.6% in 2023. This can be attributed to an increase in the incidence of cardiovascular diseases, supportive government policies, favorable reimbursement schemes, a rise in awareness, and an increase in the number of training programs
  • Asia Pacific is expected to exhibit the fastest CAGR during the forecast period due to the higher prevalence of CVDs and rapidly aging population

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Segment
    • 2.2.2. End-use Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Implantable Cardiac Rhythm Management Device Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing incidence of arrhythmia disorders
      • 3.2.1.2. Technological advancements in device functionality
      • 3.2.1.3. Rising Heart failure (HF) cases
      • 3.2.1.4. Growing geriatric population
      • 3.2.1.5. Favorable reimbursement policies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent Regulatory Policies
  • 3.3. Implantable Cardiac Rhythm Management Device Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Implantable Cardiac Rhythm Management Device Market: Product Estimates & Trend Analysis

  • 4.1. Implantable Cardiac Rhythm Management Device Market: Product Dashboard
  • 4.2. Implantable Cardiac Rhythm Management Device Market: Product Movement Analysis
  • 4.3. Implantable Cardiac Rhythm Management Device Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Pacemaker
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.2. Conventional Pacemakers
      • 4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.3. Leadless Pacemaker
      • 4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. ICDs
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Single Chamber ICDs
      • 4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Dual Chamber ICDs
      • 4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. CRT
    • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.6.2. CRT-Defibrillator
      • 4.6.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.6.3. CRT-Pacemaker
      • 4.6.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Implantable Cardiac Rhythm Management Device Market: End-use Estimates & Trend Analysis

  • 5.1. Implantable Cardiac Rhythm Management Device Market: End-use Dashboard
  • 5.2. Implantable Cardiac Rhythm Management Device Market: End-use Movement Analysis
  • 5.3. Implantable Cardiac Rhythm Management Device Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Specialty Cardiac Centers
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Implantable Cardiac Rhythm Management Device Market: Regional Estimates & Trend Analysis by Country, Product, End-use, & End-use

  • 6.1. Global Implantable Cardiac Rhythm Management Device Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Regulatory framework/ reimbursement structure
      • 6.3.4.3. Competitive scenario
      • 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Medtronic
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. End-use benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Abbott
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. End-use benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Boston Scientific Corporation
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. End-use benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Koninklijke Philips N.V.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. End-use benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Zoll Medical Corporation
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. End-use benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Biotronik
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. End-use benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Stryker
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. End-use benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Schiller AG
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. End-use benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Nihon Kohden Corporation
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. End-use benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Microport Scientific Corporation
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. End-use benchmarking
      • 7.3.13.4. Strategic initiatives